These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6482645)
21. Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. Eisenhofer G; Brush JE; Cannon RO; Stull R; Kopin IJ; Goldstein DS J Clin Endocrinol Metab; 1989 Feb; 68(2):247-55. PubMed ID: 2563731 [TBL] [Abstract][Full Text] [Related]
22. Value of the plasma norepinephrine/3,4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma. Lenders JW; Willemsen JJ; Beissel T; Kloppenborg PW; Thien T; Benraad TJ Am J Med; 1992 Feb; 92(2):147-52. PubMed ID: 1543198 [TBL] [Abstract][Full Text] [Related]
23. Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion. Akiyama T; Yamazaki T Cardiovasc Res; 2001 Jan; 49(1):78-85. PubMed ID: 11121798 [TBL] [Abstract][Full Text] [Related]
24. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation. Lambert GW; Kaye DM; Vaz M; Cox HS; Turner AG; Jennings GL; Esler MD J Auton Nerv Syst; 1995 Nov; 55(3):169-78. PubMed ID: 8801267 [TBL] [Abstract][Full Text] [Related]
25. Plasma dihydroxyphenylglycol (DHPG) in the in vivo assessment of human neuronal norepinephrine metabolism. Izzo JL; Thompson DA; Horwitz D Life Sci; 1985 Sep; 37(11):1033-8. PubMed ID: 4033349 [TBL] [Abstract][Full Text] [Related]
26. The relationship between plasma MHPG and NE: employing regression models in estimating centrally derived MHPG and peripheral NE turnover rate in panic disorder. Gurguis GN; Uhde TW J Psychiatr Res; 1998; 32(1):11-7. PubMed ID: 9693996 [TBL] [Abstract][Full Text] [Related]
27. Autonomic control after blockade of the norepinephrine transporter: a model of orthostatic intolerance. Carson RP; Diedrich A; Robertson D J Appl Physiol (1985); 2002 Dec; 93(6):2192-8. PubMed ID: 12391111 [TBL] [Abstract][Full Text] [Related]
28. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Vincent S; Bieck PR; Garland EM; Loghin C; Bymaster FP; Black BK; Gonzales C; Potter WZ; Robertson D Circulation; 2004 Jun; 109(25):3202-7. PubMed ID: 15184278 [TBL] [Abstract][Full Text] [Related]
29. Neuronal and extraneuronal uptake of norepinephrine in the human forearm. Chang PC; van Brummelen P; Vermeij P; van der Krogt JA J Hypertens Suppl; 1985 Dec; 3(3):S141-3. PubMed ID: 2856693 [TBL] [Abstract][Full Text] [Related]
30. Receptor dynamics: effect of repeated administration of desmethylimipramine on the noradrenergic systems in rat brain. Bürki HR; Rüdeberg C; Taimisto EL Postgrad Med J; 1981; 57 Suppl 1():71-6. PubMed ID: 6272253 [TBL] [Abstract][Full Text] [Related]
31. Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. Eisenhofer G; Esler MD; Goldstein DS; Kopin IJ Am J Physiol; 1991 Oct; 261(4 Pt 1):E505-15. PubMed ID: 1928342 [TBL] [Abstract][Full Text] [Related]
32. Effect of acute and chronic treatment with tricyclic antidepressants on 3-methoxy-4-hydroxyphenylethyleneglycol sulfate (MHPG-SO4) contents in various regions of rat brain. Miyauchi T; Kitada Y; Satoh S Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(2):137-42. PubMed ID: 7202235 [TBL] [Abstract][Full Text] [Related]
33. A pharmacokinetic/pharmacodynamic investigation: assessment of edivoxetine and atomoxetine on systemic and central 3,4-dihydroxyphenylglycol, a biochemical marker for norepinephrine transporter inhibition. Kielbasa W; Pan A; Pereira A Eur Neuropsychopharmacol; 2015 Mar; 25(3):377-85. PubMed ID: 25637266 [TBL] [Abstract][Full Text] [Related]
34. Plasma norepinephrine and dihydroxyphenylglycol in essential hypertension. Ludwig J; Gerlich M; Halbrügge T; Graefe KH Hypertension; 1991 Apr; 17(4):546-52. PubMed ID: 2013481 [TBL] [Abstract][Full Text] [Related]
35. Measurement of plasma norepinephrine and 3,4-dihydroxyphenylglycol: method development for a translational research study. Denfeld QE; Habecker BA; Woodward WR BMC Res Notes; 2018 Apr; 11(1):248. PubMed ID: 29673396 [TBL] [Abstract][Full Text] [Related]
36. Comparison of plasma 3,4-dihydroxyphenylethylene glycol (DHPG) and norepinephrine levels as indices of sympathetic activity in man. Howes LG; Hawksby CC; Reid JL Eur J Clin Invest; 1986 Feb; 16(1):18-21. PubMed ID: 3084267 [TBL] [Abstract][Full Text] [Related]
37. Is 3,4-dihydroxyphenylglycol the major route of central norepinephrine metabolism in rat brain? Karege F; Gaillard JM Neurosci Lett; 1986 Aug; 69(1):78-83. PubMed ID: 3748468 [TBL] [Abstract][Full Text] [Related]
38. Pharmacodynamics of norepinephrine reuptake inhibition: Modeling the peripheral and central effects of atomoxetine, duloxetine, and edivoxetine on the biomarker 3,4-dihydroxyphenylglycol in humans. Kielbasa W; Lobo E J Clin Pharmacol; 2015 Dec; 55(12):1422-31. PubMed ID: 26011686 [TBL] [Abstract][Full Text] [Related]
39. Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Eisenhofer G; Saigusa T; Esler MD; Cox HS; Angus JA; Dorward PK Am J Physiol; 1991 Apr; 260(4 Pt 2):R824-32. PubMed ID: 1672797 [TBL] [Abstract][Full Text] [Related]
40. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy. Gordon JT; Tomlinson EE; Greenberg J; Dratman MB J Pharmacol Exp Ther; 1994 Jul; 270(1):111-7. PubMed ID: 8035306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]